Form D · Biotechnology
Nymirum, Inc.
Ann Arbor, MI · CIK 0001464435
Offering snapshot reported May 22, 2009 · SEC filing
- Reported sold
- $550K Offering amount: $1M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2009 | Initial | $550,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-131441
Source: Form D, filed May 22, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edward Chandler | Director |
| J.P. Fairbank | Director, Executive |
| Michael Pape | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
117 N. First St.
Ann Arbor, MI, 48104
Ann Arbor, MI, 48104